Status:
WITHDRAWN
Voriconazole Plasma Level in Intensive Care Unit (ICU) Patients
Lead Sponsor:
Asan Medical Center
Conditions:
Invasive Fungal Infection
Eligibility:
All Genders
16+ years
Phase:
NA
Brief Summary
Voriconazole, a newer triazole-derivative, has become the drug of choice for many invasive fungal infections, including invasive Aspergillosis. Recently, therapeutic drug monitoring of voriconazole ha...
Detailed Description
Patients will be randomly assigned into 2 groups: conventional adjustment group (CA group) and early adjustment group (EA group). Voriconazole plasma levels will be measured on day 1 (both peak and tr...
Eligibility Criteria
Inclusion
- Patients who received voriconazole
Exclusion
- Patients allergic to azole(s)
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01185405
Start Date
August 1 2010
End Date
December 1 2013
Last Update
October 1 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asan Medical Center
Seoul, South Korea, 138-736